Amarin Corp Plc (AMRN)

[north40000]

A petition to the Commissioner of FDA to enforce the previous evidence-based scientific decision of FDA that Lovaza has no therapeutic efficacy/use in treatment of CVD and that FDA has not approved Lovaza for that indication might be interesting for Amarin to pursue, in light of remarks in recent CAFC opinion re Hikma’s drug.